The investigational therapy was granted Rare Pediatric Disease designation for the treatment of DMD in December and an Orphan ...

During the 6-year period, 199 new indications for solid tumors were approved by the FDA; 138 (69.3%) were also approved by EMA and 124 (62.3%) by ANVISA. Discrepancies between approved labels and the ...

Federal health officials posted a warning about misleading statements by biotech billionaire Dr. Patrick Soon-Shiong about ...

The US Food and Drug Administration (FDA) has warned a biotech company about claims that its bladder cancer drug could treat and prevent multiple types of cance ...

Medicare beneficiaries will save as much as 85% off the list price when negotiated prices for 15 blockbuster drugs go into effect in 2027, the Centers for Medicare & Medicaid Services (CMS) said ...

Ten medications accounted for nearly one-third of 340B program-covered outpatient drugs in 2024, according to a Dec. 11 report. The Health Resources and Services Administration, an HHS agency, ...

UIC researchers have successfully repurposed an FDA-approved cancer drug, doxorubicin, to treat drug-resistant strains of ...

Thousands of Medicare recipients will face higher costs for expensive cancer drugs following passage of two provisions in the One Big Beautiful Bill Act, signed by President Donald Trump in July, The ...

Pharmacy benefit managers (PBMs) have used market leverage to demand rebates, which can lead drug manufacturers to increase ...

The future of cancer drug research just might be in Omaha, Nebraska, between a Panda Express and a Mattress Firm. A big draw is speed: Nordquist says he can open a trial in as little as two weeks, ...